The United States is making more rules to control AI technologies, especially in areas like healthcare. These rules try to keep a balance between new technology and patient safety and privacy. This is hard because AI has many powers but also risks.
Medical AI is often called “high-risk” because it affects patient health directly. Because of this, government agencies and lawmakers require steps like reducing risks, using good data, and keeping human control.
The European Union (EU) has a law named the Artificial Intelligence Act (AI Act), effective from August 2024. It has strict rules for AI in healthcare about transparency, managing risks, data quality, and human control. The US does not have a similar law yet but watches these rules and thinks about making similar ones.
In the US, agencies like the Food and Drug Administration (FDA) are giving guidance about AI and machine learning software used as medical devices. They explain how AI systems should be tested, checked, and kept safe over time. The Centers for Medicare & Medicaid Services (CMS) and the Health Insurance Portability and Accountability Act (HIPAA) also affect AI through privacy and billing rules.
The FDA has recently said developers must collect “real-world performance” data. This means tracking AI devices after use to make sure they stay safe and work well.
People must trust AI systems, and this trust comes from good design and clear rules. Studies show over 60% of healthcare workers hesitate to use AI because they worry about data safety and honesty. This makes trust a big problem because staff support is needed to use AI well.
Researchers say there are seven important rules for reliable AI in healthcare:
These rules match international ones but need to be used properly in the US healthcare system.
Being able to explain AI decisions is important for trust. Explainable AI (XAI) means AI systems that show clear reasons for their decisions. This helps healthcare managers and doctors understand why AI says what it does. Then they can decide if AI’s advice makes clinical sense.
XAI helps show which patient data affected an AI diagnosis or scheduling idea. People can then trust or question the AI. Without XAI, many doctors do not fully trust AI because they fear hidden mistakes or bias.
In the US, programs are encouraging AI creators to build features that make AI easier to understand, especially where medical decisions can affect lives.
Security is a big worry when using AI in healthcare. Medical data is private and often targeted by hackers. AI can also be attacked by hackers who change inputs to trick the system and get wrong results. In 2024, a data breach involving an AI health service called WotNot showed how real this risk is.
US healthcare leaders must make sure AI tools follow HIPAA rules, do security checks regularly, and work with IT staff to protect patient info. One way is using federated learning; this lets AI learn from data spread out in different places without sharing private info centrally.
Strong cybersecurity together with government rules is needed to keep trust in AI healthcare tools.
AI can help healthcare places by automating many office tasks. This can lower paperwork, speed up work, and let medical staff focus more on patients.
Examples are:
In the US, medical managers and IT teams can use AI phone systems, like those from Simbo AI, to improve patient communication. These systems answer calls, manage appointments, and handle questions with natural language AI that fits into current workflows.
AI automation cuts costs, improves patient access, and lowers office workloads. These are goals for many US healthcare groups working with limited resources.
As AI becomes more part of medical decisions, legal responsibility gets more complex. Recent law changes say AI software makers can be responsible like manufacturers. This means if AI causes harm because of a defect, people can ask for compensation without proving fault.
Healthcare managers need to understand these legal points. Using AI with clear records, strict testing, and good human control can protect providers from legal risks. Rules often require clear explanations of AI and training for people who use it, to keep care safe.
The US may learn from the European Union’s new Product Liability Directive as it makes future rules. This will help keep patients safe and maintain public trust.
Even with AI’s promise, many challenges remain for safe and clear use in US medical offices:
Government, professional groups, and AI vendors are working together to create resources, test projects, and write policies for US healthcare needs.
The US government has started programs for AI rules and healthcare use. The FDA’s digital health precertification program and its guidance on AI/ML medical software show efforts to support new ideas safely.
The National Institutes of Health (NIH) supports research to create big, good-quality data sets for AI training and testing. Public-private partnerships aim to set standards for AI results and ethics.
Industry groups and patient advocates ask for strong rules that protect users without slowing helpful tech too much.
Medical leaders should stay updated and involved in these programs to make sure their AI use meets current and future rules and goals.
AI can help US healthcare by making workflows easier, helping with diagnoses, and personalizing patient care. But using AI right means following rules about safety, openness, privacy, and responsibility.
Medical managers and IT teams should:
By focusing on these points, healthcare offices can use AI well without risking patient safety or trust.
With careful rules and governance, AI can be a helpful and trusted part of US healthcare. It can help medical workers give safer, faster, and clearer care. The changing rules will guide safe AI use in medical settings across the country.
AI improves healthcare by enhancing resource allocation, reducing costs, automating administrative tasks, improving diagnostic accuracy, enabling personalized treatments, and accelerating drug development, leading to more effective, accessible, and economically sustainable care.
AI automates and streamlines medical scribing by accurately transcribing physician-patient interactions, reducing documentation time, minimizing errors, and allowing healthcare providers to focus more on patient care and clinical decision-making.
Challenges include securing high-quality health data, legal and regulatory barriers, technical integration with clinical workflows, ensuring safety and trustworthiness, sustainable financing, overcoming organizational resistance, and managing ethical and social concerns.
The AI Act establishes requirements for high-risk AI systems in medicine, such as risk mitigation, data quality, transparency, and human oversight, aiming to ensure safe, trustworthy, and responsible AI development and deployment across the EU.
EHDS enables secure secondary use of electronic health data for research and AI algorithm training, fostering innovation while ensuring data protection, fairness, patient control, and equitable AI applications in healthcare across the EU.
The Directive classifies software including AI as a product, applying no-fault liability on manufacturers and ensuring victims can claim compensation for harm caused by defective AI products, enhancing patient safety and legal clarity.
Examples include early detection of sepsis in ICU using predictive algorithms, AI-powered breast cancer detection in mammography surpassing human accuracy, and AI optimizing patient scheduling and workflow automation.
Initiatives like AICare@EU focus on overcoming barriers to AI deployment, alongside funding calls (EU4Health), the SHAIPED project for AI model validation using EHDS data, and international cooperation with WHO, OECD, G7, and G20 for policy alignment.
AI accelerates drug discovery by identifying targets, optimizes drug design and dosing, assists clinical trials through patient stratification and simulations, enhances manufacturing quality control, and streamlines regulatory submissions and safety monitoring.
Trust is essential for acceptance and adoption of AI; it is fostered through transparent AI systems, clear regulations (AI Act), data protection measures (GDPR, EHDS), robust safety testing, human oversight, and effective legal frameworks protecting patients and providers.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
